AnorMED conference call notification - AnorMED recommends shareholders reject dissident slate of director nominees

Name	Symbol	Market	Type
iShares Core Moderate Allocation ETF	AMEX:AOM	AMEX	Exchange Traded Fund

Name

Symbol

Market

Type

iShares Core Moderate Allocation ETF

AMEX:AOM

AMEX

Exchange Traded Fund

	Price Change	% Change	Price	High Price	Low Price	Open Price	Traded	Last Trade
	0.16	0.37%	43.37	43.39	43.2526	43.39	65,950	22:29:42

Price Change

% Change

Price

High Price

Low Price

Open Price

Traded

Last Trade

0.16

0.37%

43.37

43.39

43.2526

43.39

65,950

22:29:42

AnorMED conference call notification - AnorMED recommends shareholders reject dissident slate of director nominees

27/03/2006 3:24pm

PR Newswire (US)

Moderate Allocation ETF (AMEX:AOM)
Historical Stock Chart

From Jul 2019 to Jul 2024

Click Here for more Moderate Allocation ETF Charts.

VANCOUVER, March 27 /PRNewswire-FirstCall/ -- AnorMED Inc. (TSX: AOM) announced that it will hold a conference call and web cast today, Monday March 27, 2006 at 9:00 a.m. EST (6:00 a.m. PST) to discuss its recommendation to support the current AnorMED Management Team and Proposed Slate of Directors and reject The Baker Group's proposed slate. The web cast can be accessed through the company's web site at http://www.anormed.com/. To listen to the teleconference please dial 1-800-558-5253 in Canada and the U.S. or 1-416-626-4100 Internationally at 9:00 am EST. The reservation number required for access is No. 21288034. Participants will be in listen only mode. This call will be available on replay until April 26, 2006. AnorMED is a chemistry- based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. Information on AnorMED Inc. is available on the Company's website: http://www.anormed.com/. For further information: Elisabeth Whiting, M.Sc., Vice President, Corporate Development & Communications, Tel: (604) 532-4667, e-mail: DATASOURCE: AnorMED Inc. CONTACT: Elisabeth Whiting, M.Sc., Vice President, Corporate Development & Communications, Tel: (604) 532-4667, e-mail:

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

AOM iShares Core Moderate Allocation ETF